Chapin Davis, Inc. Astrazeneca PLC Transaction History
Chapin Davis, Inc.
- $293 Billion
- Q1 2025
A detailed history of Chapin Davis, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Chapin Davis, Inc. holds 3,873 shares of AZN stock, worth $279,204. This represents 0.1% of its overall portfolio holdings.
Number of Shares
3,873
Previous 3,227
20.02%
Holding current value
$279,204
Previous $251 Million
13.23%
% of portfolio
0.1%
Previous 0.08%
Shares
3 transactions
Others Institutions Holding AZN
# of Institutions
1,393Shares Held
473MCall Options Held
6.08MPut Options Held
4.44M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.35 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$2.96 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.7 Billion0.48% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.73 Billion0.13% of portfolio
-
Franklin Resources Inc San Mateo, CA19.5MShares$1.4 Billion0.37% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $223B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...